Literature DB >> 8163416

Cutaneous T-cell lymphoma in a cat.

J C Tobey1, D M Houston, G J Breur, M L Jackson, D A Stubbington.   

Abstract

An 8-year-old castrated male cat was examined because of a chronic, nonhealing, ulcerative lesion on the left hind limb. Cutaneous lymphoma was diagnosed on the basis of the morphologic appearance of malignant cells and Pautrier's microabscesses on light and electron microscopic examination. The tumor was found to be of T-cell origin by use of a polyclonal antibody recognizing T-cell antigen. Results of serum ELISA for FeLV were negative. The gp70 antigen of FeLV was not detected immunohistochemically in tumor tissue sections, using polyclonal goat antisera and avidin/biotin/peroxidase complex technique. Presence of FeLV was demonstrated by the polymerase chain reaction procedure, involving amplification of a 166-base pair region of FeLV DNA. Although FeLV is reported to be the cause of most types of lymphoma in cats, cats with epitheliotropic cutaneous lymphoma have consistently negative test results for circulating FeLV antigen. In such cases, using the polymerase chain reaction method, tumor DNA may be assessed for integrated FeLV provirus and the presence of FeLV can be confirmed.

Entities:  

Mesh:

Year:  1994        PMID: 8163416

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Epitheliotropic lymphoma in a dog.

Authors:  H Bouchard
Journal:  Can Vet J       Date:  2000-08       Impact factor: 1.008

2.  High prevalence of non-productive FeLV infection in necropsied cats and significant association with pathological findings.

Authors:  M Suntz; K Failing; W Hecht; D Schwartz; M Reinacher
Journal:  Vet Immunol Immunopathol       Date:  2010-03-25       Impact factor: 2.046

3.  Multifocal cutaneous non-epitheliotropic B-cell lymphoma in a cat.

Authors:  Fausto Quintavalla; Rosanna Di Lecce; Daniele Carlini; Matteo Zanfabro; Anna M Cantoni
Journal:  JFMS Open Rep       Date:  2020-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.